Masimo Co. (MASI) Shares Bought by Ladenburg Thalmann Financial Services Inc.

Ladenburg Thalmann Financial Services Inc. increased its stake in shares of Masimo Co. (NASDAQ:MASI) by 8.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,650 shares of the medical equipment provider’s stock after buying an additional 759 shares during the quarter. Ladenburg Thalmann Financial Services Inc.’s holdings in Masimo were worth $835,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in MASI. DekaBank Deutsche Girozentrale grew its holdings in shares of Masimo by 78.3% during the third quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock valued at $182,000 after buying an additional 925 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Masimo by 13.2% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,018 shares of the medical equipment provider’s stock valued at $184,000 after buying an additional 236 shares during the last quarter. Advisor Group Inc. grew its holdings in shares of Masimo by 38.4% during the second quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock valued at $216,000 after buying an additional 655 shares during the last quarter. Intellectus Partners LLC purchased a new stake in shares of Masimo during the second quarter valued at $237,000. Finally, Shelton Capital Management purchased a new stake in shares of Masimo during the second quarter valued at $269,000. 83.69% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Masimo Co. (MASI) opened at $85.09 on Friday. Masimo Co. has a 1-year low of $66.79 and a 1-year high of $104.71. The company has a market cap of $4,400.00, a price-to-earnings ratio of 33.45, a price-to-earnings-growth ratio of 2.94 and a beta of 0.72.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 EPS for the quarter, beating the consensus estimate of $0.53 by $0.17. Masimo had a net margin of 45.83% and a return on equity of 22.17%. The company had revenue of $193.69 million for the quarter, compared to analyst estimates of $189.01 million. During the same period in the prior year, the company earned $0.52 earnings per share. The firm’s revenue was up 15.6% on a year-over-year basis. analysts predict that Masimo Co. will post 2.95 EPS for the current fiscal year.

In other news, Director Steven Barker sold 10,000 shares of the stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total transaction of $900,000.00. Following the sale, the director now directly owns 73,249 shares of the company’s stock, valued at approximately $6,592,410. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Yongsam Lee sold 5,000 shares of the stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $89.89, for a total transaction of $449,450.00. Following the sale, the executive vice president now directly owns 74,000 shares in the company, valued at $6,651,860. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 53,074 shares of company stock worth $4,737,245. 16.60% of the stock is owned by corporate insiders.

Several research firms have commented on MASI. Stifel Nicolaus reaffirmed a “buy” rating and issued a $108.00 price target on shares of Masimo in a report on Friday, November 3rd. Zacks Investment Research raised shares of Masimo from a “hold” rating to a “buy” rating and set a $98.00 price target on the stock in a report on Thursday, November 2nd. Finally, BidaskClub lowered shares of Masimo from a “hold” rating to a “sell” rating in a report on Thursday, December 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $97.17.

ILLEGAL ACTIVITY WARNING: “Masimo Co. (MASI) Shares Bought by Ladenburg Thalmann Financial Services Inc.” was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.com-unik.info/2017/12/22/masimo-co-masi-shares-bought-by-ladenburg-thalmann-financial-services-inc.html.

About Masimo

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

What are top analysts saying about Masimo? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Masimo and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit